The Foundation Fighting Blindness has promoted Jason Menzo to CEO and Russell Kelley, PhD, MBA, to managing director of the Retinal Degeneration Fund, according to a press release.
The leadership changes will take effect July 1.
Ben Yerxa, PhD, who has served as CEO of the foundation since 2017, will transition to CEO of Opus Genetics.
Menzo joined the Foundation Fighting Blindness in 2018 and has served as president and chief operating officer since January 2022. Kelley previously served as the RD Fund’s senior vice president of investments and alliances.
(Read more...)